ライフサイエンスコーパス: foramen

1 jor optic nerve blood vessels at the scleral foramen.

2 skull ossification and persistent calvarial foramen.

3 a mean of 11.4 mm from the greater palatine foramen.

4 facial nerve transection at the stylomastoid foramen.

5 sterior crista (PC) and the utriculosaccular foramen.

6 that eventually exited through the nutrient foramen.

7 e meninges and lining the anterior lacerated foramen.

8 to the SN, and the SN in the greater sciatic foramen.

9 oop of the mental nerve mesial to the mental foramen.

10 e right atrium may result in widening of the foramen and consequently, cause serious conditions due t

11 pect to verifying the position of the mental foramen and validating the presence of an anterior loop

12 ior medial pterygoid tubercle, mesial mental foramen, and narrow corpus place it closer to early mode

13 Pertinent muscles, blood supply, foramen, and nerve innervations that may be encountered

14 terior to, posterior to, or above the mental foramen; and prior to placing an implant anterior to the

15 III) was noticed, especially over the mental foramen area.

16 cells were also hypoplastic, leaving an open foramen at birth.

17 We trace the origin of the calvarial foramen defect in Msx2 mutant mice to a group of skeleto

18 lars, while they are close to the mandibular foramen in Ank (+/+) mice.

19 heterozygous loss of Twist function causes a foramen in the skull vault similar to that caused by los

20 or vena cava subsequently passed through the foramen into the left atrium.

21 The mental foramen is a strategically important landmark during ost

22 lip sensations are preventable if the mental foramen is located and this knowledge is employed when p

23 position when an anterior loop of the mental foramen is suspected of being present or if it is unclea

24 syndrome, skull base fractures involving the foramen lacerum, neck soft tissue injury, or neurologica

25 However, it has unilateral mandibular foramen lingular bridging, an apparently derived Neander

26 blood flow (CBF) and ventriculostomy defect, foramen magnum (FM), and cerebral aqueduct CSF flow.

27 In these disorders, spinal canal and foramen magnum stenosis can cause serious neurologic com

28 Spinal canal and foramen magnum stenosis in heterozygous achondroplasia p

29 Tonsillar herniation, foramen magnum stenosis, and severe osteomyelitis of the

30 nal cord tumor extending from just above the foramen magnum to C6.

31 h tonsils extending more than 5 mm below the foramen magnum were classified by the neurosurgeon as sy

32 death (all intracranial structures above the foramen magnum), cerebral death (all supratentorial stru

33 ntrol of the location and orientation of the foramen magnum, and changes in the breadth of the basioc

34 Besides a relatively anterior foramen magnum, humans differ from apes in the lateral s

35 of a chronic catheter introduced through the foramen magnum.

36 lumbar vertebrae, loss of synchondroses, and foramen-magnum shape anomalies.

37 The mental foramen may be oval or round and is usually located apic

38 The foramen may not appear on conventional radiographs, and

39 the position, number, and size of the mental foramen, mental nerve anatomy, and consequences of nerve

40 Measurements of the mental foramen (MF) included height (MF-H), width (MF-W), and l

41 men that is deeper than the safety zone, the foramen must be probed to exclude the possibility that a

42 al nerve may be present mesial to the mental foramen needs to be considered before implant surgery to

43 , and their typical location adjacent to the foramen of Monro.

44 Hernias through the foramen of Winslow are extremely rare, accounting for 0.

45 Herniation through the foramen of Winslow is a difficult diagnosis and must not

46 lated at its entry to the lesser sac via the foramen of Winslow was confirmed.

47 ed" as a search platform using the keywords "foramen of Winslow" and "hernia".

48 ith strangulated ileum herniated through the foramen of Winslow.

49 on of the inferior alveolar nerve and mental foramen on panoramic and periapical films prior to impla

50 in 50 consecutive patients with a sublabral foramen or Buford complex at arthroscopy.

51 sensitivity of MR for diagnosing a sublabral foramen or Buford complex was 0.94 (47 of 50 patients, 9

52 and accuracy of MR for depicting a sublabral foramen or Buford complex were calculated along with 95%

53 m-type atrial septal defect (n=12) or patent foramen ovale (n=5) by a totally endoscopic approach, ut

54 ients 18 to 60 years of age who had a patent foramen ovale (PFO) and had had a cryptogenic ischemic s

55 A causal relationship between patent foramen ovale (PFO) and migraine has been hypothesized,

56 evention of embolism in patients with patent foramen ovale (PFO) and otherwise unexplained ischemic s

57 ischemic attack presumably related to patent foramen ovale (PFO) are at risk for recurrent cerebrovas

58 The role of a patent foramen ovale (PFO) as a risk factor for ischemic stroke

59 Patent foramen ovale (PFO) can be detected in up to 43% of pati

60 -documented, those for catheter-based patent foramen ovale (PFO) closure are still evolving.

61 patients who underwent transcatheter patent foramen ovale (PFO) closure for paradoxical embolism.

62 Percutaneous transcatheter patent foramen ovale (PFO) closure is now standard practice and

63 Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke

64 The role of surgical closure of patent foramen ovale (PFO) for cerebral infarction (CI) or tran

65 close atrial septal defects (ASD) and patent foramen ovale (PFO) has a number of limitations, includi

66 Patent foramen ovale (PFO) has been associated with migraine, b

67 ss the risk of ischemic stroke from a patent foramen ovale (PFO) in the multiethnic prospective cohor

68 The efficacy of closure of a patent foramen ovale (PFO) in the prevention of recurrent strok

69 The patent foramen ovale (PFO) is a normal interatrial communicatio

70 Patent foramen ovale (PFO) is associated with cryptogenic strok

71 Patent foramen ovale (PFO) is associated with stroke, but there

72 Patent foramen ovale (PFO) is experiencing increased clinical i

73 Patent foramen ovale (PFO) is implicated in platypnea-orthodeox

74 Patent foramen ovale (PFO) is prevalent in patients with migrai

75 Percutaneous transcatheter closure of patent foramen ovale (PFO) is used as an alternative to surgery

76 A patent foramen ovale (PFO) may permit arterial embolization of

77 ectiveness of percutaneous closure of patent foramen ovale (PFO) plus medical therapy versus medical

78 Patent foramen ovale (PFO) was detected with contrast injection

79 -to-left shunted blood flow through a patent foramen ovale (PFO) would not be cooled.

80 with atrial septal aneurysm (SA) and patent foramen ovale (PFO), and to determine the efficacy of me

81 to determine the association between patent foramen ovale (PFO), atrial septal aneurysm (ASA), and s

82 headache symptoms in patients with a patent foramen ovale (PFO), both of which conditions are highly

83 to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical ce

84 Controversy surrounds the issue of patent foramen ovale (PFO), stroke, and secondary prevention st

85 ulting in a right-to-left shunt via a patent foramen ovale (PFO).

86 res to repair incidentally discovered patent foramen ovale (PFO).

87 ifty-four (86%) had effective closure of the foramen ovale (trivial or no residual shunt by echocardi

88 The prevalence of patent foramen ovale among patients with cryptogenic stroke is

89 The association of patent foramen ovale and atrial septal aneurysm with stroke is

90 Patients with a patent foramen ovale and ischemic stroke, transient ischemic at

91 Patent foramen ovale and pulmonary arteriovenous shunts are ass

92 aphy identified three patients with a patent foramen ovale and right-to-left shunt flow while breathi

93 cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medic

94 e closure (9 secundum ASDs and 4 with patent foramen ovale associated with a cerebral vascular accide

95 Foramen ovale blood flow (QFO = LVCO-QP) was estimated.

96 results using these tools to perform patent foramen ovale closure are described.

97 in 4 and repair in 2, CABG in 2, and patent foramen ovale closure in 5.

98 pparent increased risk for concurrent patent foramen ovale closure or mitral or tricuspid repair.

99 alysis demonstrated that simultaneous patent foramen ovale closure was not associated with an increas

100 a demonstration of both technologies, patent foramen ovale creation and closure was performed in a sw

101 mainly the adult population, such as patent foramen ovale device closure and closure of postinfarct

102 ients, all of whom underwent recordings with foramen ovale electrodes and scalp electroencephalogram.

103 mesial temporal activity using intracranial foramen ovale electrodes in two patients with Alzheimer'

104 Closure of a patent foramen ovale for secondary prevention of cryptogenic em

105 Patent foramen ovale has been associated with increased risk of

106 lowed by ostium secundum ASD in 6 and patent foramen ovale in 4.

107 benefit associated with closure of a patent foramen ovale in adults who had had a cryptogenic ischem

108 The Patent foramen ovale In Cryptogenic Stroke Study (PICSS) evalua

109 th warfarin or aspirin as part of the Patent Foramen Ovale in Cryptogenic Stroke Study (PICSS), based

110 hocardiograms in 11 patients showed a patent foramen ovale in one patient but no systemic source of e

111 that occur in the major veins and across the foramen ovale in the circulation of the fetal lamb.

112 Whether closure of a patent foramen ovale is effective in the prevention of recurren

113 e of percutaneous closure devices for patent foramen ovale is reviewed.

114 d paradoxical emboli in patients with patent foramen ovale is unknown.

115 Transcatheter closure of patent foramen ovale may prevent a substantial proportion of cr

116 e (11%), aortic valve procedure (9%), patent foramen ovale or atrial septal defect closure (23%), car

117 Whether closure of a patent foramen ovale reduces the risk of recurrence of ischemic

118 diseases causing stroke, the role of patent foramen ovale remains controversial.

119 A strong inverse relationship between foramen ovale shunt and pulmonary blood flow was noted (

120 The wide range we found in foramen ovale shunting suggests a degree of variability

121 closure of an atrial septal defect or patent foramen ovale to assess how the procedure affected migra

122 sus stream preferentially passed through the foramen ovale to the left atrium.

123 Foramen ovale volume blood flow (left ventricular cardia

124 <.001), and DA volume blood flow (P<.01) and foramen ovale volume blood flow (P<.03) decreased.

125 cept for 19.6 +/- 2.3% of the cycle when the foramen ovale was closed during atrial contraction.

126 In the second group, the patent foramen ovale was not successfully created in 1 animal,

127 of medical therapy (895 patients) for patent foramen ovale were included.

128 theter closure or medical therapy for patent foramen ovale were required to include at least 10 patie

129 Here, we report stenting of the foramen ovale with a large, open-cell stent via percutan

130 ly assigned to undergo closure of the patent foramen ovale with the Amplatzer PFO Occluder or to rece

131 f the ten patients undergoing semi-invasive (foramen ovale) electrode monitoring reveals that for at

132 d in 47% (including 17% with isolated patent foramen ovale), and 11% had undetermined stroke etiology

133 (0, 160); umbilical vein, 134 (62, 206); and foramen ovale, 135 (37, 233).

134 16 (0, 34); umbilical vein, 29 (11, 47); and foramen ovale, 29 (7, 51).

135 (TAA), 88% had left-to-right flow across the foramen ovale, 91% had monophasic mitral inflow, and 94%

136 Patent foramen ovale, alone or together with ASA, was not assoc

137 patients had simultaneous closure of patent foramen ovale, and 19 patients had other various cardiac

138 (RAP) score (comprising the tricuspid valve, foramen ovale, and ductus venosus Doppler).

139 persistent pulmonary hypertension, a patent foramen ovale, and free-floating right-heart thrombus ar

140 ion of the inferior vena cava, right atrium, foramen ovale, and left atrium with a guidewire and 1.8F

141 ccult paroxysmal atrial fibrillation, patent foramen ovale, aortic arch atherosclerosis, atrial cardi

142 has been reported in patients with a patent foramen ovale, carcinoid tumor of the lung, and active c

143 h cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device did not offer a gre

144 One possible exception is patent foramen ovale, for which high-risk features may warrant

145 en pulmonary embolism coexists with a patent foramen ovale, increased pressure in the right atrium ma

146 rmal LV length, reversed flow in the TAA and foramen ovale, monophasic mitral inflow, and LV dysfunct

147 ing of intracranial atheroma, patent cardiac foramen ovale, or elevated levels of antiphospholipid an

148 re of secundum atrial septal defects, patent foramen ovale, patent ductus arteriosus, stent placement

149 ntrast transcranial doppler to detect patent foramen ovale.

150 enosus, in both venae cavae, and through the foramen ovale.

151 the stent was successfully positioned in the foramen ovale.

152 cell stent was positioned in an unrestricted foramen ovale.

153 dical therapy alone or closure of the patent foramen ovale.

154 ations or percutaneous closure of the patent foramen ovale.

155 sient ischemic attack (TIA) and had a patent foramen ovale.

156 ited to pulmonary artery stenosis and patent foramen ovale.

157 paradoxical embolism due to existing patent foramen ovale.

158 Of 11 patients, 5 (45%) had a patent foramen ovale; 1 of these also had a primary lung carcin

159 utility in quantitative assessment of patent foramen ovales (PFO).

160 Patent foramen ovales (PFOs) are common congenital cardiac defe

161 Patent foramen ovales vary in both anatomical and functional si

162 All patent foramen ovales were completely closed in the first group

163 and utilizing the rib as a conduit into the foramen provided an advantage in patients with osteopeni

164 nerve; surgical corroboration of the mental foramen's position when an anterior loop of the mental f

165 r chamber and in having the glossopharyngeal foramen separated from the metotic fissure.

166 s (FMNs) survive axotomy at the stylomastoid foramen (SMF), whereas, before postnatal day 15 (P15), d

167 s are more accurate for detecting the mental foramen than conventional radiographs.

168 r of neurons with somata near the esophageal foramen that gave rise to arborizations in the protocere

169 to placing an implant anterior to the mental foramen that is deeper than the safety zone, the foramen

170 trally as they progressed toward the scleral foramen (the mouse does not have a lamina cribrosa), and

171 Cdh23 is expressed in the urticulo-saccular foramen,the ductus reuniens, and Reissner's membrane, su

172 portion of the orbit primarily via the optic foramen; they travel only short distances and end blindl

173 lear how much bone is present coronal to the foramen to establish a zone of safety (in millimeters) f

174 ined at 5-mm increments distal to the mental foramen to the ascending ramus.